Liu Juan, Yang Chao, Huang Xiao-Mei, Lv Pan-Pan, Yang Ya-Kun, Zhao Jin-Na, Zhao Si-Yuan, Sun Wan-Jun
Department of Hematology, PLA Rocket Force Characteristic Medical Center, Beijing, China.
Department of Neurosurgery, Beijing Huicheng Medical Research Institute, Beijing, China.
Front Oncol. 2021 Nov 12;11:796839. doi: 10.3389/fonc.2021.796839. eCollection 2021.
The transcription suppressor factor FBI-1 (the factor that binds to inducer of short transcripts-1) is an important regulator of hepatocellular carcinoma (HCC). In this work, the results showed that FBI-1 promoted the Warburg effect and enhances the resistance of hepatocellular carcinoma cells to molecular targeted agents. Knockdown of FBI-1 its small-interfering RNA (siRNA) inhibited the ATP level, lactate productions, glucose uptake or lactate dehydrogenase (LDH) activation of HCC cells. Transfection of siFBI-1 also decreased the expression of the Warburg-effect-related factors: hypoxia-inducible factor-1 alpha (HIF-1α), lactate dehydrogenase A (LDHA), or GLUT1, and the epithelial-mesenchymal transition-related factors, Vimentin or N-cadherin. The positive correlation between the expression of FBI-1 with HIF-1α, LDHA, or GLUT1 was confirmed in HCC tissues. Mechanistically, the miR-30c repressed the expression of HIF-1α by binding to the 3'-untranslated region (3'-UTR) of HIF-1α in a sequence-specific manner, and FBI-1 enhanced the expression of HIF-1α and HIF-1α pathway's activation by repressing the expression of miR. By modulating the miR-30c/HIF-1α, FBI-1 promoted the Warburg effect or the epithelial-mesenchymal transition of HCC cells and promoted the resistance of HCC cells to molecular targeted agents.
转录抑制因子FBI-1(与短转录本诱导物-1结合的因子)是肝细胞癌(HCC)的重要调节因子。在本研究中,结果表明FBI-1促进了瓦伯格效应并增强了肝癌细胞对分子靶向药物的抗性。通过小干扰RNA(siRNA)敲低FBI-1可抑制肝癌细胞的ATP水平、乳酸生成、葡萄糖摄取或乳酸脱氢酶(LDH)活性。转染siFBI-1还降低了与瓦伯格效应相关因子的表达:缺氧诱导因子-1α(HIF-1α)、乳酸脱氢酶A(LDHA)或葡萄糖转运蛋白1(GLUT1),以及上皮-间质转化相关因子波形蛋白或N-钙黏蛋白。在肝癌组织中证实了FBI-1与HIF-1α、LDHA或GLUT1表达之间的正相关。机制上,miR-30c通过以序列特异性方式结合HIF-1α的3'-非翻译区(3'-UTR)来抑制HIF-1α的表达,而FBI-1通过抑制miR的表达来增强HIF-1α的表达及HIF-1α通路的激活。通过调节miR-30c/HIF-1α,FBI-1促进了肝癌细胞的瓦伯格效应或上皮-间质转化,并促进了肝癌细胞对分子靶向药物的抗性。